{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:46:37Z","timestamp":1790419597757,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.rmed.2021.106536","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:03:29Z","timestamp":1625637809000},"page":"106536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effect of one-year dextromethorphan\/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"186","author":[{"given":"Jesus","family":"Sancho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Bur\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Luis D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Torrecilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Signes-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Servera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2021.106536_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.50.1.66","article-title":"Prognostic indicators of survival in ALS. CNTF treatment study group","volume":"50","author":"Stamler","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.rmed.2021.106536_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1183\/23120541.00159-2017","article-title":"Bulbar impairment score and survival of stable amyotrophic lateral sclerosisafter noninvasive ventilation initiation","volume":"4","author":"Sancho","year":"2018","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.rmed.2021.106536_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial","volume":"5","author":"Bourke","year":"2006","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.rmed.2021.106536_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","article-title":"The phenotypic variability of amyotrophic lateral sclerosis","volume":"10","author":"Swinnen","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.rmed.2021.106536_bib5","first-page":"23","article-title":"The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration","volume":"3","author":"King","year":"2013","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.rmed.2021.106536_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamainternmed.2018.6112","article-title":"Assessment of use of combined dextromethorphan and quinidine in patients with dementia or Parkinson disease after US Food and Drug administration approval for pseudobulbar affect","volume":"17982","author":"Fraclick","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.rmed.2021.106536_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-014-0018-5","article-title":"Review of dextromethorphan 20mg\/quinidine 10 mg (Nuedexta) for pseudobulbar affect","volume":"31","author":"Pioro","year":"2014","journal-title":"Neurol Ther"},{"issue":"3","key":"10.1016\/j.rmed.2021.106536_bib8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s13311-016-0508-5","article-title":"Enhanced bulbar function in amyotrophic lateral sclerosis: the Nuedexta clinical trial","volume":"14","author":"Smith","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.rmed.2021.106536_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ana.22093","article-title":"Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect","volume":"68","author":"Pioro","year":"2010","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.rmed.2021.106536_bib10","first-page":"293","article-title":"World federation neurology research group on motor neuron diseases. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler."},{"issue":"12","key":"10.1016\/j.rmed.2021.106536_bib11","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1212\/WNL.39.12.1635","article-title":"A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis","volume":"989","author":"Lacomblez","year":"1989","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.rmed.2021.106536_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jnnp.63.1.89","article-title":"A self report measure of affective lability","volume":"63","author":"Moore","year":"1997","journal-title":"J Neurol Neurosurg Psychitry"},{"issue":"1\u20132","key":"10.1016\/j.rmed.2021.106536_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS function ranting scale that incorporates assessment of respiratory function. DNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurl Sci"},{"issue":"Suppl 16","key":"10.1016\/j.rmed.2021.106536_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows: report of working party \u201cstandardization of lung function test\u201d","volume":"6","author":"Quanjer","year":"1993","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2021.106536_bib15","first-page":"696","article-title":"Maximal respiratory pressures: normal values and relationship to age and sex","volume":"99","author":"Black","year":"1969","journal-title":"Am. Rev. Respir. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2021.106536_bib16","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1183\/09031936.06.00121305","article-title":"Sniff nasal inspiratory pressure: what is the optimal number of sniffs?","volume":"27","author":"Lofaso","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2021.106536_bib17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1164\/rccm.200612-1841OC","article-title":"Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis","volume":"175","author":"Sancho","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2021.106536_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1378\/chest.116.2.521","article-title":"Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD and nocturnal hypoventilation: a Consensus Conference Report","volume":"116","year":"1999","journal-title":"Chest"},{"issue":"7\u20138","key":"10.1016\/j.rmed.2021.106536_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/21678421.2017.1335324","article-title":"Effectiveness of assisted and unassisted cough capacity in amyotrophic lateral sclerosis patients","volume":"18","author":"Sancho","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"10.1016\/j.rmed.2021.106536_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","article-title":"EFNS guidelines on Clinical management of amyotrophic lateral sclerosis (MALS)- revised report of an EFNS task force","volume":"19","author":"Andersen","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.rmed.2021.106536_bib21","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/brain\/124.9.1708","article-title":"Pathological laughter and crying: a link to the cerebellum","volume":"124","author":"Parvizi","year":"2001","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.rmed.2021.106536_bib22","first-page":"89","article-title":"Prism II: an open label study to assess effectiveness of dextromethorphan\/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic injury","volume":"16","author":"Hammond","year":"2016","journal-title":"BCM Neurol"},{"issue":"11","key":"10.1016\/j.rmed.2021.106536_bib23","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1185\/03007995.2014.940040","article-title":"An open-label multicenter study to assess the safety of dextromethorphan\/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions","volume":"30","author":"Pattee","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.rmed.2021.106536_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0269216317709965","article-title":"Caregiver burden in amyotrophic lateral sclerosis: a systematic review","volume":"32","author":"de Wit","year":"2018","journal-title":"Palliat. Med."},{"key":"10.1016\/j.rmed.2021.106536_bib25","series-title":"Innovate Care for Chronic Conditions: Building Blocks for Action","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.rmed.2021.106536_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/VHRM.S9252","article-title":"Feasibility and effectiveness of a disease and care management in the primary health care system for patients with heart failure and diabetes (Project Leonardo)","volume":"6","author":"Ciccone","year":"2010","journal-title":"Vasc. Health Risk Manag."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121002420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121002420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:25:37Z","timestamp":1760617537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611121002420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":26,"alternative-id":["S0954611121002420"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106536","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of one-year dextromethorphan\/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106536"}}